Butabarbital
Butabarb, Butalan, Buticaps, Butisol, Sarisol (butabarbital) is a small molecule pharmaceutical. Butabarbital was first approved as Butisol sodium on 1982-01-01. It is used to treat sleep initiation and maintenance disorders in the USA.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Butabarbital sodium
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BUTISOL SODIUM | Mylan | N-000793 DISCN | 1982-01-01 | 4 products |
Hide discontinued
Labels
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
61 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | 3 | — | 1 | 2 | 6 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | 1 | 1 | 1 | 1 | 4 |
| Autism spectrum disorder | D000067877 | F84.0 | — | 2 | — | 1 | 1 | 4 | |
| Depression | D003863 | F33.9 | — | 1 | 1 | 1 | — | 3 | |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | — | 2 | — | 1 | — | 3 |
| Marijuana abuse | D002189 | EFO_0007191 | F12 | — | 2 | — | 1 | — | 3 |
| Sleep apnea syndromes | D012891 | EFO_0003877 | G47.3 | — | 1 | — | 1 | — | 2 |
| Dyspepsia | D004415 | EFO_0008533 | K30 | 1 | 1 | — | 1 | — | 2 |
| Hypothermia | D007035 | HP_0002045 | T68 | — | — | — | 1 | — | 1 |
| Williams syndrome | D018980 | Orphanet_904 | Q93.82 | — | — | — | 1 | — | 1 |
Show 3 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Schizophrenia | D012559 | EFO_0000692 | F20 | — | — | 2 | — | — | 2 |
| Autistic disorder | D001321 | EFO_0003758 | F84.0 | 1 | 2 | 1 | — | — | 2 |
| Dementia | D003704 | F03 | — | — | 1 | — | — | 1 | |
| Psychophysiologic disorders | D011602 | F45.9 | — | — | 1 | — | — | 1 | |
| Heart failure | D006333 | EFO_0003144 | I50 | — | — | 1 | — | — | 1 |
| Central sleep apnea | D020182 | G47.31 | — | — | 1 | — | — | 1 | |
| Ischemic stroke | D000083242 | — | — | 1 | — | — | 1 | ||
| Neoplasms | D009369 | C80 | — | 1 | 1 | — | — | 1 | |
| Dyspnea | D004417 | HP_0002094 | R06.0 | — | 1 | 1 | — | — | 1 |
| Psychotic disorders | D011618 | F20.81 | — | — | 1 | — | — | 1 |
Show 1 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Spinal cord injuries | D013119 | EFO_1001919 | 3 | 4 | — | — | — | 6 | |
| Cocaine-related disorders | D019970 | F14 | — | 2 | — | — | 1 | 3 | |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | 1 | — | — | — | 2 |
| Psychological sexual dysfunctions | D020018 | F52.0 | — | 2 | — | — | — | 2 | |
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | 1 | 1 | — | — | — | 2 |
| Attention deficit disorder with hyperactivity | D001289 | EFO_0003888 | F90 | — | 1 | — | — | — | 1 |
| Gastroparesis | D018589 | EFO_1000948 | K31.84 | — | 1 | — | — | — | 1 |
| Quadriplegia | D011782 | HP_0002510 | G82.5 | 1 | 1 | — | — | — | 1 |
| Smoking cessation | D016540 | EFO_0004319 | 1 | 1 | — | — | — | 1 | |
| Tobacco use cessation | D020340 | 1 | 1 | — | — | — | 1 |
Show 5 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | 2 | — | — | — | — | 2 | ||
| Therapeutic equivalency | D013810 | 2 | — | — | — | — | 2 | ||
| Movement disorders | D009069 | EFO_0004280 | G25 | 1 | — | — | — | — | 1 |
| Dyskinesias | D020820 | G24 | 1 | — | — | — | — | 1 | |
| Chronic pain | D059350 | HP_0012532 | 1 | — | — | — | — | 1 | |
| Psychological dependency | D003858 | 1 | — | — | — | — | 1 | ||
| Systemic scleroderma | D012595 | EFO_0000717 | M34 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | — | — | — | — | 1 | 1 |
| Traumatic brain injuries | D000070642 | S06 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | BUTABARBITAL |
| INN | secbutabarbital |
| Description | Butabarbital is a member of barbiturates. |
| Classification | Small molecule |
| Drug class | barbituric acid derivatives |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CCC(C)C1(CC)C(=O)NC(=O)NC1=O |
Identifiers
| PDB | — |
| CAS-ID | 125-40-6 |
| RxCUI | 477631 |
| ChEMBL ID | CHEMBL449 |
| ChEBI ID | 3228 |
| PubChem CID | 2479 |
| DrugBank | DB00237 |
| UNII ID | P0078O25A9 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 32 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
4,281 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more